Sort
35,931 grants matching “parkinsons”
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE
$293,680Georgia Institute Of Technology · R01 · FY2003 · DA
Exendin-4 and neurodegenerative diseases
$293,661Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2009 · AG
Cognitive intervention to improve simple and complex walking
$293,577Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2019 · AG
High performance PET Detector Module for Human Brain Imaging
$293,568Peng Peng · Canon Medical Research Usa, Inc. · R01 · FY2019 · EB
Mechanism of high-efficiency transduction of hepatocytes by optimized AAV vectors
$293,563Arun Srivastava · University Of Florida · R01 · FY2019 · GM
Mechanism of high-efficiency transduction of hepatocytes by optimized AAV vectors
$293,563Arun Srivastava · University Of Florida · R01 · FY2021 · GM
Mechanism of high-efficiency transduction of hepatocytes by optimized AAV vectors
$293,563Arun Srivastava · University Of Florida · R01 · FY2020 · GM
Mechanism of high-efficiency transduction of hepatocytes by optimized AAV vectors
$293,563Chen Ling · University Of Florida · R01 · FY2017 · GM
Genetic Analysis of the PINK1-Parkin Pathway
$293,550Leo J Pallanck · University Of Washington · R01 · FY2014 · GM
Genetic Analysis of the PINK1-Parkin Pathway
$293,550Leo J Pallanck · University Of Washington · R01 · FY2016 · GM
Genetic Analysis of the PINK1-Parkin Pathway
$293,550Leo J Pallanck · University Of Washington · R01 · FY2013 · GM
Genetic Analysis of the PINK1-Parkin Pathway
$293,550Leo J Pallanck · University Of Washington · R01 · FY2015 · GM
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES
$293,532John Q. Trojanowski · University Of Pennsylvania · P01 · FY2014 · AG
fMRI Studies of the Neural Basis of Reward Processing
$293,529University Of Pittsburgh At Pittsburgh · R01 · FY2002 · DA
Toxic Metal Complexation By de Novo Designed Peptides
$293,524Vincent L. Pecoraro · University Of Michigan At Ann Arbor · R01 · FY2014 · ES
Development of Novel p38 MAPK Inhibitors as Therapeutics for CNS Disorders
$293,487D. Martin Watterson · Northwestern University At Chicago · R01 · FY2012 · AG
Development of Novel p38 MAPK Inhibitors as Therapeutics for CNS Disorders
$293,487D. Martin Watterson · Northwestern University At Chicago · R01 · FY2011 · AG
Protein folding by the universally conserved GroEL (Hsp60) chaperone machine and
$293,475Costa Georgopoulos · University Of Utah · R01 · FY2010 · GM
Amphetamine Regulation of Dopamine Transport
$293,469Aurelio Antonio Galli · Vanderbilt University · R01 · FY2009 · DA
BDNF rs6265 and Response to Dopaminergic Therapy in PD
$293,467Caryl E Sortwell · Michigan State University · R21 · FY2016 · NS
ALPHA-SYNUCLEIN-INDUCED AMYLOIDOSIS
$293,461John Q. Trojanowski · University Of Pennsylvania · P01 · FY2007 · AG
Multiplex interrogation of neuromodulatory signaling in behaving animals with enhanced depth and resolution
$293,443Lin Tian · University Of California At Davis · U01 · FY2023 · NS
SCH: An Augmented Reality Neurorehabilitation System for Monitoring and Management of Motor Symptoms of Parkinson's Disease
$293,419Henry Fuchs · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HD
DEVELOPMENT OF POTENTIALLY SELECTIVE DOPAMINE AGONISTS
$293,417Purdue University West Lafayette · R01 · FY2002 · MH
De-Differentiating Adult Human Fibroblasts into Stem-Like Cells Using Conditions
$293,402Tanja Dominko · Worcester Polytechnic Institute · R01 · FY2009 · GM